Shengkai Li: h-index, Total Citations, and Citation Map
Shengkai Li's h-index is 9 (9 i10-index, 399+ total citations across 28+ publications) according to Google Scholar as of June 2026. Shengkai Li is affiliated with Iotabiome Biotechnolgy Co,.Ltd.
Shengkai Li is a researcher affiliated with Iotabiome Biotechnolgy Co,.Ltd, specializing in Genetics, Molecular Epidemiology, Machine learning. Their work has been cited 399 times. This profile visualizes their global influence, highlighting strong citation networks in China.
Shengkai Li's Citation Metrics
Bibliometric impact based on 28 indexed publications.
- H-Index
- 9
- i10-Index
- 9
- Total Citations
- 399
- Citing Countries
- 30
As of June 2026.
Shengkai Li has an h-index of 9 and 399 total citations across 28 publications, with research cited by institutions in 30 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Shengkai Li's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Resurgence of Mycoplasma pneumonia by macrolide-resistant epidemic clones in China
2024114
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
206 citing papers could not be classified (no author data) — excluded from the percentages above.
The researcher established a genomic framework linking centralized industrial pork production to the global dissemination of Salmonella enterica, subsequently extending this analytical approach to characterize emerging multidrug-resistant pathogens in clinical settings.
The researcher identified a dominant multidrug-resistant Acinetobacter baumannii clade and analyzed how healthcare infrastructure shapes its evolutionary trade-offs and global dissemination.
The researcher identified the resurgence of macrolide-resistant Mycoplasma pneumoniae epidemic clones in China and investigated post-pandemic microbiome interactions, establishing a critical framework for understanding evolving respiratory pathogen dynamics.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About Shengkai Li's research
Shengkai Li is a researcher in Genetics, Molecular Epidemiology and Machine learning at Iotabiome Biotechnolgy Co,.Ltd. Their work has been cited 399 times across 28 publications (h-index 9), according to Google Scholar.
Their most-cited work, “Resurgence of Mycoplasma pneumonia by macrolide-resistant epidemic clones in China” (2024), has accumulated 114 citations. Other influential works include “Emergence and global spread of a dominant multidrug-resistant clade within Acinetobacter baumannii” (2025) with 40 citations and “Albuca Bracteate Polysaccharides Synergistically Enhance the Anti-Tumor Efficacy of 5-Fluorouracil Against Colorectal Cancer by Modulating β-Catenin Signaling …” (2021) with 39 citations.
Citations of Shengkai Li's research come primarily from China, United States and India, reflecting international research impact across 5+ countries. The interactive citation map above shows the full geographic distribution of the institutions citing this work.
